MAY 18, 2018

Accreditation Explosion Among Top SP Trends

By David Wild

Las Vegas—The specialty pharmacy industry is simultaneously thriving yet facing pressures, including copay accumulators and vertical integration, that could slow that growth, some of the foremost experts on the topic told attendees of the 2018 Asembia Specialty Pharmacy Summit.

Growth of the Industry

According to Adam Fein, PhD, the CEO of Drug Channels Institute, a subsidiary of Philadelphia-based Pembroke Consulting Inc., the increasing use of specialty drugs means

To read the full story, Log in or Sign up for a Free Account

Operations & Management